FGL2 and nonpapillary renal cell carcinoma: However, no significant correlation was observed between FGL2 expression and OS and RFS of patients with advanced-stage ccRCC (TNM stage, III + IV; log-rank test: P > 0.05) because of their small sample size (Fig. S2A,B).